Validation of the Montreal Cognitive Assessment and Noninvasive Neuroimaging Markers in Early Diagnosis of Alzheimer’s Disease in an African American Population
Aim: The proposed study will validate the use of a cognitive screening assessment, known as the Montreal Cognitive Assessment tool (MoCA) to differentiate normal cognition from mild cognitive impairment (MCI), a diagnosis associated with increased risk for developing Alzheimer’s disease (AD).
Principal Investigator: Chad Yucus, MD
IRB Approval Number: EH11-041
Funding Source: University of Chicago CTSA
Contact: Please call 847.503.4322 with any questions regarding the study
Open to Enrollment: Yes

× Alternate Text